Published in J Invest Dermatol on August 01, 1991
Duality of the immune response in cancer: lessons learned from skin. J Invest Dermatol (2014) 0.84
Post-transplantation malignancies: here today, gone tomorrow? Nat Rev Clin Oncol (2015) 0.81
The development of squamous cell carcinoma in a patient after kidney transplantation: a case report. Postepy Dermatol Alergol (2013) 0.78
HLA-A11 in renal allograft recipients with skin cancer. J Invest Dermatol (1992) 0.75
Leukocyte proliferation in vitro against cottontail rabbit papillomavirus in rabbits with persisting papillomas/cancer or after regression. Arch Dermatol Res (1995) 0.75
Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis (1989) 6.52
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet (1994) 5.58
Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med (1995) 5.16
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet (1995) 5.10
Genetic influence on cytokine production and fatal meningococcal disease. Lancet (1997) 4.89
QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation (1991) 4.37
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ (2009) 4.18
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet (1992) 4.15
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med (1996) 4.11
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet (1995) 4.01
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet (1993) 3.87
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet (1992) 3.58
Case reports in an evidence-based world. J R Soc Med (1999) 3.55
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med (1999) 3.22
Is publication bias a medical problem? Lancet (1993) 3.04
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood (1995) 2.96
Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med (1991) 2.93
Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet (1995) 2.79
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med (1993) 2.70
Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ (1994) 2.54
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Cerebral Venous Sinus Thrombosis Study Group. Lancet (1998) 2.42
Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol (1993) 2.40
Osteoarthritis and obesity in the general population. A relationship calling for an explanation. J Rheumatol (1988) 2.39
Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol (1984) 2.38
Antipsychotic medication and venous thrombosis. Br J Psychiatry (2001) 2.37
Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol (1995) 2.33
Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet (1991) 2.31
Bungee-jumping and design of experiments. Lancet (1992) 2.31
Mortality in hereditary antithrombin-III deficiency--1830 to 1989. Lancet (1991) 2.31
Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet (1996) 2.30
Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int (1999) 2.26
New public health and old rhetoric. BMJ (1994) 2.18
Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int (1999) 2.17
Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) Blood (1995) 2.09
Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods (1993) 2.08
Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation (1990) 2.07
Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis (1990) 2.07
No increase in mortality and morbidity among carriers of the C282Y mutation of the hereditary haemochromatosis gene in the oldest old: the Leiden 85-plus study. Eur J Clin Invest (2002) 2.07
Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol (1997) 2.03
Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol (1998) 2.01
Psychiatric disorders in relation to medical illness among patients of a general medical out-patient clinic. Psychol Med (1993) 2.01
Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum (1990) 2.01
Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands. Lancet (1996) 1.99
Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med (1999) 1.95
Prospective or retrospective: what's in a name? BMJ (1991) 1.82
Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup. J Rheumatol (1984) 1.75
The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation (1996) 1.75
The Leiden Thrombophilia Study (LETS). Thromb Haemost (1997) 1.65
Should we abandon statistical modeling altogether? Am J Epidemiol (1987) 1.64
Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands. Diabetologia (2002) 1.63
Usefulness of patient interview in bleeding disorders. Arch Intern Med (1995) 1.62
The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up. Ann Rheum Dis (1983) 1.61
Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. JAMA (1986) 1.59
Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood (1995) 1.58
Pregnancy and severe aplastic anaemia: causal relation or coincidence? . Br J Haematol (1998) 1.56
Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol (1998) 1.54
Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. J Pediatr (2000) 1.53
Treatment of eczema herpeticum with acyclovir. Arch Dermatol (1983) 1.52
Nonulcer dyspepsia in a Dutch working population and Helicobacter pylori. Ulcer history as an explanation of an apparent association. Arch Intern Med (1995) 1.52
Relation between smoking and skin cancer. J Clin Oncol (2001) 1.50
The mortality of rheumatoid vasculitis compared with rheumatoid arthritis. Arthritis Rheum (1996) 1.50
The role of compliance as a cause of instability in oral anticoagulant therapy. Br J Haematol (1997) 1.48
Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab (2007) 1.47
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies]. Internist (Berl) (2008) 1.47
Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore) (1997) 1.46
Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro. Transplantation (2001) 1.46
In defense of Farr and Nightingale. Ann Intern Med (1996) 1.46
Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. Br J Rheumatol (1992) 1.46
The determination of lipids and proteins in suction blister fluid. J Invest Dermatol (1979) 1.46
Competing interests and controversy about third generation oral contraceptives. BMJ readers should know whose words they read. BMJ (2000) 1.45
The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods (1994) 1.43
Permanent detrimental effect of nonimmunological factors on long-term renal graft survival: a parsimonious model of time-dependency. Transplantation (2000) 1.42
Maintaining privacy and the health of the public. Should not be seen as in opposition. BMJ (1998) 1.42
Renal allograft rejection and antibodies to epithelial cells. Lancet (1992) 1.42
Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens. Transplantation (2001) 1.41
[Epoetin-induced pure red-cell aplasia]. Ned Tijdschr Geneeskd (2004) 1.41
Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS). Thromb Haemost (1994) 1.41
[The thrombosis service as a source of information for studies in patients with heart valve prostheses]. Ned Tijdschr Geneeskd (1992) 1.40
Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet (2001) 1.39
Geographical variance in the risk of gastric stump cancer: no increased risk in Japan? Jpn J Cancer Res (1991) 1.39
[The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis]. Ned Tijdschr Geneeskd (2005) 1.39
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression. Transplantation (2001) 1.39
Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol (1994) 1.39
[Physicians and scientific research: slight decline of the numbers of physicians with a doctoral degree]. Ned Tijdschr Geneeskd (2006) 1.39
Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans. Arch Dermatol (1997) 1.39
[Pruritus in systemic diseases; pathogenesis and treatment]. Ned Tijdschr Geneeskd (1994) 1.39
Mortality in patients with epilepsy: 40 years of follow up in a Dutch cohort study. J Neurol Neurosurg Psychiatry (1999) 1.39
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38
Immunomodulation by intrathymic injection of donor leukocytes in rhesus monkeys. Transplantation (2001) 1.37
High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol (1995) 1.35
Prediction of osteoporotic fractures in the general population by a fracture risk score. A 9-year follow-up among middle-aged women. Am J Epidemiol (1990) 1.34
Pregnancy and the risk of developing rheumatoid arthritis. Arthritis Rheum (1990) 1.33
Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis (1994) 1.33